Results 251 to 260 of about 243,277 (388)
Abstract Aims Young‐onset type 2 diabetes mellitus (YT2DM) is an aggressive phenotype, with some claiming that diagnosis at <40 years of age represents a distinct higher risk group. Others have suggested restricting YT2DM to those diagnosed at <30 years of age.
Xi May Zhen+14 more
wiley +1 more source
Assessment of the ability to predict complications of the Risk Factor Scale for Pre-eclampsia Complications and the fullPIERS scale in pregnant women in a Hospital in Lima, Peru. [PDF]
Aquino-Vásquez PN+3 more
europepmc +1 more source
Different blood pressure response to the cold pressor test predicts preeclampsia [PDF]
Christian Woisetschläger+5 more
openalex +1 more source
Abstract Aims To compare markers of glycaemic regulation in twin and singleton pregnancies in women with gestational diabetes mellitus (GDM). Methods A retrospective case–control study was performed. 53 twin and 212 matched singleton pregnant women with gestational diabetes were included. Data were obtained from patient files.
Ninna L. Larsen+5 more
wiley +1 more source
Severe Preeclampsia and High Frequency of Genetic Thrombophilic Mutations [PDF]
Michael J. Kupferminc+5 more
openalex +1 more source
Abstract Objective(s) Pregnancy in women with epilepsy is associated with adverse perinatal outcomes, but debate remains as to role of epilepsy or of prenatal antiseizure medication (ASM), or both. We aimed to investigate the association between maternal epilepsy and perinatal outcomes, and to explore the role of prenatal ASM exposure.
Paolo Pieirino Mazzone+5 more
wiley +1 more source
The Impact of Maternal Education on Neonatal Outcomes in Preeclamptic Pregnancies from a Low-Resource Settings. [PDF]
Buciu VB+10 more
europepmc +1 more source
Pregnancy Complicated by Severe Preeclampsia and Thrombocytopenia in a Patient with Scleroderma
Robert D′Angelo, Robert Miller
openalex +1 more source
Abstract Objectives/Background Nearly 12% of Americans experience migraine, with 75% of that group represented by women aged 15–55 years, notably including peak childbearing years. This presents a therapeutic dilemma for pregnant patients, given that most medications for migraine range from unknown teratogenicity in human pregnancies, at best, to known
Liza Smirnoff+4 more
wiley +1 more source